• Skip to Main Content
  • Skip to Footer
CFF Homepage
  • What Is CF?
    X close

    ABOUT CYSTIC FIBROSIS

    Learn about cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs, and how to treat and live with this chronic disease.

    Role of Genetics in CF

    CF is a rare genetic disease found in about 30,000 people in the U.S. If you have CF or are considering testing for it, knowing about the role of genetics in CF can help you make informed decisions about your health care.

    CF Genetics: The Basics
    CF Mutations Video Series
    Find Out More About Your Mutations
    Personalized Medicine
    Types of CFTR Mutations

    DIAGNOSIS

    If you or your child has just been diagnosed with cystic fibrosis, or your doctor has recommended testing for CF, you may have many questions.

    TESTING FOR CYSTIC FIBROSIS

    Diagnosing CF is a multistep process. A complete diagnostic evaluation should include a newborn screening, a sweat chloride test, a genetic or carrier test, and a clinical evaluation at a CF Foundation-accredited care center.

    Carrier Testing for Cystic Fibrosis
    CFTR-Related Metabolic Syndrome (CRMS)
    How Babies Are Screened in IRT-Only vs. IRT-DNA States
    Newborn Screening for CF
    Sweat Test
  • Life With CF
    X close

    Caring for a Child With CF

    Raising a child with cystic fibrosis can bring up many questions because CF affects many aspects of your child’s life. Here you’ll find resources to help you manage your child’s daily needs and find the best possible CF care.

    CF Infant Care
    PARENT AND GUARDIAN GUIDANCE

    Working With Your Child's School

    Individualized Education Programs (IEPs) and 504 Plans
    School Transitions for People With CF and Their Families

    Daily Life

    Living with cystic fibrosis comes with many challenges, including medical, social, and financial. By learning more about how you can manage your disease every day, you can ultimately help find a balance between your busy lifestyle and your CF care.

    Adult Guide to Cystic Fibrosis

    CF and School

    For Teachers
    Managing My CF in College
    CYSTIC FIBROSIS-RELATED DIABETES

    Emotional Wellness

    Procedural Anxiety
    Substance Misuse
    Depression
    Coping While Caring for Someone With Cystic Fibrosis
    Anxiety
    Working With Your Care Team

    Fitness and Nutrition

    Fitness
    Nutrition and Your Digestive System

    Germs and Staying Healthy

    CF and Coronavirus (COVID-19)
    How Can You Avoid Germs
    What Are Germs?

    Traveling With CF

    Preparing to Travel
    In Transit and at the Destination
    Special Considerations While Traveling Abroad

    Transitions

    People with CF are living longer, healthier lives than ever before. As an adult with CF, you may reach key milestones you might not have considered. Planning for these life events requires careful thought as you make decisions that may impact your life.

    Managing My CF in College

    Accommodations for College
    Scholarships and Financial Aid

    Reproductive Health and Fertility

    Contraception and Protection
    How Does CF Affect the Female Reproductive System?
    How Does CF Affect the Male Reproductive System?
    Sex and CF: Some Practical Advice

    Family Planning and Parenting With CF

    Making Your Family Planning Decisions
    Pregnancy and CF
    Alternative Ways to Build a Family
    Parenting as an Adult With CF

    Colorectal Cancer and CF

    About Colorectal Cancer
    Preparing for a Colonoscopy When You Have CF
    What Happens After My Colonoscopy?

    Treatments and Therapies

    People with cystic fibrosis are living longer and more fulfilling lives, thanks in part to specialized CF care and a range of treatment options.

    Airway Clearance

    Active Cycle of Breathing Technique
    Airway Clearance Techniques
    Autogenic Drainage
    Basics of Lung Care
    Chest Physical Therapy
    Coughing and Huffing
    High-Frequency Chest Wall Oscillation
    Positive Expiratory Pressure

    Clinical Trials

    Clinical Trials 101
    What to Consider When Joining a Clinical Trial
    After the Clinical Trial: What’s Next?

    Lung Transplantation

    Being Referred and Evaluated
    Surgery, Recovery, and Life Post-Transplant
    Waiting for the Transplant
    What Is a Lung Transplant?
    What to Consider Regarding a Lung Transplant

    Medications

    Antibiotics
    Bronchodilators
    CFTR Modulator Therapies
    Mucus Thinners
    Nebulizer Care at Home
    Vascular Access Devices PICCs and Ports

    Partnerships for Sustaining Daily Care

    More Than Taking Medications
    The Partnerships for Sustaining Daily Care Initiative

    Treatment Plan

    CF Care Center Visits
    Managing Your Treatment Plan
    Partnering With Your Care Team
    Trikafta
  • Care
    X close

    Care Centers

    Cystic Fibrosis Foundation-accredited care centers provide expert care and specialized disease management to people living with cystic fibrosis.

    CF CARE CENTER finder

    We provide funding for and accredit more than 120 care centers and 53 affiliate programs nationwide. The high quality of specialized care available throughout the care center network has led to the improved length and quality of life for people with CF.

    Clinical Care Guidelines

    The Cystic Fibrosis Foundation provides standard care guidelines based on the latest research, medical evidence, and consultation with experts on best practices.

    Age-specific Care Guidelines

    Adult Care Clinical Care Guidelines
    Infant Care Clinical Care Guidelines
    Management of CRMS in First 2 Years and Beyond Clinical Care Guidelines
    Preschool-Aged Care Clinical Care Guidelines
    CFTR Modulator Therapy Care Guidelines

    Diagnosis Care Guidelines

    CF Diagnosis Clinical Care Guidelines
    Newborn Screening Clinical Care Guidelines
    Sweat Test Clinical Care Guidelines

    Infection Prevention and Control Care Guidelines

    Allergic Bronchopulmonary Aspergillosis Clinical Care Guidelines
    Eradication of Initial P aeruginosa Clinical Care Guidelines
    Infection Prevention and Control Clinical Care Guidelines
    Nontuberculous Mycobacteria Clinical Care Guidelines

    Nutrition and GI Care Guidelines

    Colorectal Cancer Screening Clinical Care Guidelines
    Enteral Tube Feeding Clinical Care Guidelines
    Nutrition in Children and Adults Clinical Care Guidelines
    Nutrition in Pediatrics Clinical Care Guidelines
    Pancreatic Enzymes Clinical Care Guidelines
    Vitamin D Deficiency Clinical Care Guidelines

    Other CF-related Conditions Care Guidelines

    Bone Disease in CF Clinical Care Guidelines
    Cystic Fibrosis-Related Diabetes Clinical Care Guidelines
    Liver Disease Clinical Care Guidelines

    Respiratory Care Guidelines

    CF Airway Clearance Therapies Clinical Care Guidelines
    Chronic Medications to Maintain Lung Health Clinical Care Guidelines
    Guidelines for the Care of Individuals With Advanced CF Lung Disease
    Lung Transplant Referral Guidelines
    Pneumothorax and Hemoptysis Clinical Care Guidelines
    Pulmonary Exacerbations Clinical Care Guidelines
    SCREENING & TREATING DEPRESSION & ANXIETY GUIDELINES
    Best Practices in the Management of the Gastrointestinal Aspects of CF

    Clinician Resources

    As a clinician, you’re critical in helping people with CF maintain their quality of life. We’re committed to helping you partner with patients and their families by providing resources you can use to improve and continue to provide high-quality care.

    Clinician Awards

    Clinician Career Development Awards
    Clinician Training Awards
    Mutation Analysis Program

    Network News

    Network News: February 2020
    Network News: NACFC 2019
    Network News: August 2019
    Network News: May 2019
    Network News: Previous Issues

    Partnerships for Sustaining Daily Care

    As part of the Cystic Fibrosis Foundation's mission to help improve the lives of people living with cystic fibrosis, the PSDC initiative taps the CF community to inform key efforts to support the management of daily care.

    MORE THAN TAKING MEDICATIONS
    The Partnerships for Sustaining Daily Care Initiative
    Success With Therapies Research Consortium

    Your CF Care Team

    Your cystic fibrosis care team includes a group of CF health care professionals who partner with you to provide specialized, comprehensive CF care.

  • Assistance Services
    X close

    About Compass

    Many people living with cystic fibrosis and their families face complicated issues related to getting the care they need. Cystic Fibrosis Foundation Compass makes sure that no one has to do it alone.

    What Is Compass?
    Meet the Compass Team

    How Compass Helps People With CF and Their Families

    CF Foundation Compass is a service that helps people with CF and their families with navigating insurance options, connecting to legal information and experts, finding available financial resources, and tackling other life issues.

    How Compass Can Help

    Understanding Insurance

    Medicaid
    Medicare
    Your Insurance Plan
    Social Security Disability
    Know Your Legal Rights

    Financial Matters

    Financial Planning
    Finding Financial Assistance
    Postsecondary Transitions
    Other Life Issues
    Disaster and Emergency Preparedness Plan

    How Compass Can Help CF Care Teams

    CF care team members are paramount in providing highly specialized care to people living with CF. CF Foundation Compass can help by serving as a strategic ally for care teams, so team members can focus on their patients’ care.

    Connect With Compass

    CF Foundation Compass can help you navigate insurance, financial, legal, and other issues you are facing. Use this online form to start your conversation with a Compass case manager today.

  • Research
    X close

    About Our Research

    The Cystic Fibrosis Foundation is the world’s leader in the search for a cure for CF and supports a broad range of research initiatives to tackle the disease from all angles.

    Path to a Cure
    Research We Fund
    RESEARCH OVERVIEW
    RESEARCH MILESTONES
    Track Record of Progress
    New Developments in Clinical Research
    Cystic Fibrosis Foundation Therapeutics Lab

    Developing New Treatments

    The CF Foundation offers a number of resources for learning about clinical trials and treatments that are being developed to improve the treatment of cystic fibrosis.

    CFTR Modulator Types

    Clinical Trials

    Clinical Trials 101
    What to Consider When Joining a Clinical Trial
    After the Clinical Trial: What’s Next?
    CLINICAL TRIAL FINDER
    DRUG DEVELOPMENT PIPELINE

    Drug Development Pipeline 101

    About the Drug Development Pipeline
    How Drugs Get on the Pipeline
    Trailblazer CF Clinical Trials Campaign

    Research Into the Disease

    Our understanding of CF continues to evolve as scientists study what causes the disease and how it affects the body. These insights drive the development of new and better treatments and bring us one step closer to a cure.

    Research Into CF Complications

    Gastrointestinal Issues and Cystic Fibrosis-Related Diabetes
    Infection Research Initiative
    Infections
    Inflammation
    Mucus

    Restore CFTR Function

    Basics of the CFTR Protein
    CFTR Modulator Types
    Exploring Treatments for Nonsense and Rare Mutations
    Gene Therapy for Cystic Fibrosis
    Gene Editing for Cystic Fibrosis
    Gene Delivery for Cystic Fibrosis Therapy
    Stem Cells for Cystic Fibrosis Therapy

    Role of Genetics in CF

    CF Genetics The Basics
    CF Mutations Video Series
    Find Out More About Your Mutations
    Personalized Medicine
    Types of CFTR Mutations

    Researcher Resources

    Researchers, supported by the CF Foundation, have made tremendous advances to improve the health and quality of life of people with CF. We are committed to providing the tools and resources you need to continuously build upon this work.

    Awards and Grants

    Applicant Resources
    Career Development Awards
    COVID-19 FAQs for Applicants and Awardees
    Funding Opportunities
    Research Awards
    Training Awards
    CF BASIC RESEARCH CENTERS
    Community Input into Research
    Industry Funding Opportunities
    National Resource Centers

    North American CF Conference

    2020 NACFC
    Carolyn and C. Richard Mattingly Leadership in Mental Health Care Award
    Mary M. Kontos Award
    Paul di Sant’Agnese Distinguished Scientific Achievement Award
    Quality Care Awards
    Richard C. Talamo Distinguished Clinical Achievement Award
    Robert J. Beall Therapeutics Development Award

    Patient Registry

    2019 Patient Registry Annual Data Report
    2019 Cystic Fibrosis Foundation Patient Registry Snapshot
    Care Center Data
    Understanding Changes in Life Expectancy

    Research Consortia

    CF Biomarker Consortium
    CFTR 3-D Structure Consortium
    CFTR Folding Consortium
    Epithelial Stem Cell Consortium
    Mucociliary Clearance Consortium
    NTM Consortium
    SUCCESS WITH THERAPIES RESEARCH CONSORTIUM

    Therapeutics Development Network

    TDN Coordinating Center Study Support
    TDN Womens Health Research Working Group
    Working With the TDN

    Tools and Resources

    Antimicrobial Tools and Resources
    Bioinformatics Tools for CF
    Cell Model Resources
    CFTR Antibodies Distribution Program
    CFTR Assays
    CF Foundation Biorepository
    CFTR Chemical Compound Program
    CFTR Protein Domains
    Patient Registry Data Requests
  1. About Us
  2. News
  3. Blog
  4. Chapters
  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Email
DONATE
GET INVOLVED
Breadcrumb Navigation
  1. Home
  2. Care
  3. Clinical Care Guidelines

Best Practices in the Management of the Gastrointestinal Aspects of CF

A panel of pediatric and adult gastroenterologists created this document to summarize and disseminate the existing medical literature regarding cystic fibrosis-specific gastrointestinal disease.

Share
  • Facebook
  • Twitter
  • Email
  • Print

Share

  • Facebook
  • Twitter
  • Email
  • Print

Best Practices in the Management of the Gastrointestinal Aspects of Cystic Fibrosis

Freedman SD, Wilschanski M (eds.) Best Practices in the Management of the Gastrointestinal Aspects of Cystic Fibrosis. J Cyst Fibros. 2017 Nov;16 Suppl

Purpose and Background

A 3-year clinical training program for pediatric and adult gastroenterologists named DIGEST (Developing Innovative Gastrointestinal Specialty Training) was created to address gastrointestinal (GI) care for people with cystic fibrosis. The group developed an initiative to compile and review existing medical literature related to specific GI disease in CF, summarize the information, and disseminate this knowledge through the publication of a GI-related supplement to the Journal of Cystic Fibrosis. The work was carried out by pairing pediatric and adult gastroenterologists (DIGEST trainees and mentors/senior authors) in an international, collaborative writing effort.

Methodology

The journal supplement was developed to address 10 key CF-specific GI topic areas, providing reviews aiming to educate non-gastroenterologist CF care providers. Each article included:

  • Background
  • Physiology
  • Pathophysiology
  • Clinical presentation
  • Diagnostic work up
  • Routine management
  • A summary of potential clinical endpoints
  • Future directions

Where there was sufficient evidence and agreement across the literature, the authors proposed algorithms on how to approach the evaluation and management of these disorders and diseases.

Most of these articles reviewed current understanding of genotype-phenotype relationships.

Areas Discussed

Manuscript Topics Included
Gastroesophageal reflux disease:

Physiology and pathophysiology specific to CF


Unique aspects of reflux and CF: complications, emerging concepts, and controversies

Bacterial overgrowth, dysbiosis, inflammation, and dysmotility:  

Pathophysiology specific to CF, including:

  • the CF intestine, inflammation, motility, and the microbiota
  • antibiotic use as a constant remodeling agent for the microbiome

Routine evaluation methodologies, emerging modalities for assessment and management

Chronic abdominal pain:  

Pathophysiology specific to CF: differentiation of types of pain, red flags for pain

  • CF related appendicitis, fibrosing colonopathy, and medication-related pain
  • Risk factors for, and the unique presentation of, Clostridium difficile-related colitis that every patient and physician should be aware of
Meconium Ileus:

Associated conditions and observations

Distal intestinal obstruction syndrome (DIOS), constipation, and colorectal cancer:

Differentiation of constipation in CF from that in non-affected individuals and from DIOS


Pathophysiology and risk factors in CF, including:

  • The relationship between steatorrhea and DIOS risk
  • Fluid management
  • Controversies regarding fiber in CF
  • The importance of adequate pancreatic enzyme replacement therapy
  • Use of N-acteylcysteine, contrast enemas as therapy
  • A review of medications and efficacy in CF

Colorectal cancer in patients with CF, and the importance of adequate screening and surveillance in this at increased risk population

Cystic fibrosis-related cirrhosis:  

Pathophysiology and emerging concepts with respect to mechanisms of risk and description of the spectrum of hepatobiliary involvement in CF and patterns observed


Evaluation (including the examination) and management specific to CF


Use of ursodeoxycholic acid including concepts and controversies and dosing recommendations

Gallbladder and bile duct disease:  

Specific risk factors including: environmental factors, luminal factors, and effect of transplantation


Concepts and controversies regarding use of ursodeoxycholic acid

Pancreatic insufficiency:

Current status of indirect and direct testing for exocrine pancreatic insufficiency


Pancreatic enzyme replacement therapy and novel emerging therapies

Pancreatitis and pancreatic cystosis:  

Intrinsic and extrinsic factors, cystic fibrosis transmembrane conductance regulator (CFTR) modulators, and a model for risk for pancreatitis related to CFTR function and acinar reserve


Mechanisms and risk factors for development of cystosis and management algorithm

Prevention and management of nutritional failure:  

Nutritional status and interventions on current and future outcomes with respect to growth, pulmonary function, and other outcomes of clinical interest


Timing and targets/goals of nutritional therapy and multidisciplinary approach to evaluation and management

Themes

Several themes that run across disorders reviewed in this publication include:

  • Throughout the GI tract, CFTR mutations have significant impact on epithelial surfaces resulting in alterations in salt, water, and pH balance. These alterations result in pathophysiologic cascades unique to people with CF and necessitating management approaches different than those for the general population.
  • Because of this altered pathophysiology, many disease presentations in people with CF are different and distinct from those observed in the general population. Early recognition of these atypical presentations may be critically important to management and long-term outcomes.
  • People with CF are living longer as a result of clinical advances in care. Furthermore, long-term consequences of impaired CFTR function, intrinsic, extrinsic, environmental, and medication effects, and chronic inflammation may be part of the pathophysiology leading to an increased incidence of GI cancers. Clinicians must be cognizant of these factors as people with CF live longer and the early detection of GI malignancies becomes increasingly important.
  • Finally, the risk of esophageal, colorectal, biliary, and gallbladder cancers is significantly increased post lung transplant.

Unanswered Questions

  • Published literature is several years to decades old. Significant limitations in the interpretation of this literature exist because of changes in diagnostic technologies and management strategies. There is a critical need to update clinical practice guidelines to reflect current practice.
  • By identifying these gaps and potential clinical end points, the published review articles have highlighted specific questions and areas for future collaboration.
  • The emergence of the widespread use of CFTR modulators holds promise for improving CF-specific GI management. Close observation will be needed to determine the long-term effects of these therapies on GI function in CF and how that translates to disease management.

Further Reading

  • Carrion A, Borowitz DS, Freedman SD, et al. Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis with Ivacaftor: Case Series. J Pediatr Gastroenterol Nutr. 2018 Mar; 66 (3):451-454. doi: 10.1097/MPG.0000000000001788.
  • Knotts RM, Solfisburg QS, Keating C, et al. Cystic fibrosis is associated with an increased risk of Barrett's esophagus.J Cyst Fibros. 2018 Nov S1569-1993(18)30933-0. doi: 10.1016/j.jcf.2018.11.005. Epub 2018 Nov 23.
  • Liu K, Wang X, Zou C, et al. Defective CFTR promotes intestinal proliferation via inhibition of the hedgehog pathway during cystic fibrosis. Cancer Lett. 2019 Jan 10. S0304-3835(19)30008-4. doi: 10.1016/j.canlet.2018.12.018. Epub 2019 Jan 11
  • Zhu X, Gao L, Yan C, He Y. A novel role and mechanism of cystic fibrosis transmembrane conductance regulator in bisphenol A-induced prostate cancer. J Cell Biochem. 2018 Nov 28. doi: 10.1002/jcb.28156. [Epub ahead of print]
  • Platt KD, Sondhi AR, DiMagno MJ. Pancreatic Cancer: A Rare Cause of Abdominal Pain in Severe Cystic Fibrosis. Pancreas. 2019 Jan; 48(1):e3-e4. doi: 10.1097/MPA.0000000000001162
  • Gelfond D, Heltshe S, Ma C, et al. Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation. Clin Transl Gastroenterol. 2017 Mar 16; 8(3):e81. doi: 10.1038/ctg.2017.10.

This executive summary was prepared by:

Steven D Freedman MD (Beth Israel Deaconess Medical Center), Asim Maqbool, MD (The University of Pennsylvania Perelman School of Medicine)

Share this Page

  • Facebook
  • Twitter
  • Email

Related Topics

  • How Are CF Clinical Care Guidelines Developed?
  • Taking Care of Your Digestive System
  • Enzymes
  • Use the Right Gastrointestinal Medications

Further Reading

  • Holiday Meals and Enzymes

Follow Us On

  1. Facebook
  2. Twitter
  3. YouTube
  4. Instagram
  5. Email
CFF Homepage

Cystic Fibrosis Foundation

4550 Montgomery Ave.
Suite 1100 N
Bethesda, MD 20814

301-951-4422

800-344-4823 (toll free)

Better Business Bureau Accredited Charity
We will not rest until we find a cure. Donate
  • About Us
    • About the Foundation
    • Media Center
    • Attendance Policy
    • Our Approach to Federal State and Local Policy
    • Board of Trustees
    • Our History
    • Careers
    • Our Leadership
    • Contact Us
    • Reports and Financials
    • Governance and Policies
  • What is CF?
    • About Cystic Fibrosis
    • CF Genetics
    • Diagnosis
    • Testing for CF
  • Life With CF
    • Caring for a Child With CF
    • Daily Life
    • En Español
    • Transitions
    • Treatments and Therapies
  • Care
    • Care Centers
    • Clinical Care Guidelines
    • Clinician Resources
    • Find a CF Care Center
    • Partnerships for Sustaining Daily Care
    • Your CF Care Team
  • Research
    • About Our Research
    • Developing New Treatments
    • Research Into the Disease
    • Researcher Resources
  • Assistance Services
    • Compass Service Request
    • Connect With Compass
    • How Compass Can Help CF Care Teams
    • How Compass Helps People With CF and Their Families
  • Get Involved
    • Advocate
    • Attend an Event
    • Connect
    • Fundraise
    • Give to the Cause
    • Volunteer

Sign up for our emails

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Email
  • Privacy Statement
  • Email Opt-Out
  • Legal Terms & Conditions
  • Charity Disclosures
  • En Español